Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Feb 14, 2024; 30(6): 542-555
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.542
Table 1 Comparative analysis of clinical indicators and spectral computed tomography parameters between groups
VariablesTraining cohort (n = 172)
Validation cohort (n = 85)
LVI/PNI (+)
LVI/PNI (-)
P value
LVI/PNI (+)
LVI/PNI (-)
P value
Gender, n (%)
    Male77 (61.1)49 (38.9)0.81847 (70.2)20 (29.8)0.109
    Female29 (63.0)17 (37.0)9 (50.0)9 (50.0)
Age, yr, n (%)
    < 6033 (66.0)17 (34.0)0.45019 (67.9)9 (32.1)0.788
    ≥ 6073 (59.8)49 (40.2)37 (64.9)20 (35.1)
CT-T
    T1/223 (30.3)53 (69.7)< 0.001a9 (28.1)23 (71.9)< 0.001a
    T3/483 (86.5)13 (13.5)47 (88.7)6 (11.3)
CT-N
    N029 (34.9)54 (65.1)< 0.001a19 (55.8)24 (44.2)< 0.001a
    N1/2/377 (86.5)12 (13.5)36 (12.2)5 (87.8)
CT-EMVI
    Negative44 (41.5)62 (58.5)< 0.001a20 (45.5)24 (54.5)< 0.001a
    Positive62 (6.1)4 (93.9)36 (87.8)5 (12.2)
CA72-4, n (%)
    Negative86 (57.3)64 (42.7)0.002a46 (63.9)26 (36.1)0.528
    Positive20 (90.9)2 (9.1)10 (76.9)3 (23.1)
AFP, n (%)
    Negative104 (61.5)65 (38.5)1.00054 (65.9)28 (34.1)1.000
    Positive2 (66.7)1 (33.3)2 (66.7)1 (33.3)
CEA, n (%)
    Negative91 (61.1)58 (38.9)0.70442 (61.8)26 (38.2)0.109
    Positive15 (65.2)8 (34.8)14 (82.4)3 (17.6)
CA199, n (%)
    Negative89 (58.6)63 (41.4)0.022a48 (64.0)27 (36.0)0.483
    Positive17 (85.0)3 (15.0)8 (80.0)2 (20.0)
CA125, n (%)
    Negative101 (60.5)66 (39.5)0.15854 (65.9)28 (34.1)1.000
    Positive5 (100.0)0 (0.0)2 (66.7)1 (33.3)
VP-70 kev, mean ± SD92.46 ± 18.2964.54 ± 15.90< 0.001a89.87 ± 20.3466.30 ± 18.65< 0.001a
EP-NIC, mean ± SD0.68 ± 0.160.49 ± 0.13< 0.001a0.69 ± 0.150.51 ± 0.12< 0.001a